Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid
The NICE final draft guidance on Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes, on which the BSPED was a consultee, has been released.
We are pleased to announce that Helen Storr has been appointed by the BSPED Executive as the Research Group Chair. Sinead McGlacken-Byrne and James Law will be joint deputy chairs as Sinead will be shortly on maternity leave. The leads are currently reviewing the applications for members to join the group and will have their first meeting shortly.